These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36324078)

  • 21. [Respiratory failure can be seen in chronic inflammatory demyelinating polyneuropathy: a case report].
    Christani M
    Lakartidningen; 2022 Feb; 119():. PubMed ID: 35147209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
    Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
    Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP).
    Klehmet J; Märschenz S; Ruprecht K; Wunderlich B; Büttner T; Hiemann R; Roggenbuck D; Meisel A
    Clin Chem Lab Med; 2018 May; 56(6):919-926. PubMed ID: 29329103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg).
    van Schaik IN; Vermeulen M; van Doorn PA; Brand A
    J Neuroimmunol; 1994 Oct; 54(1-2):109-15. PubMed ID: 7929799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy.
    Marsh EA; Hirst CL; Llewelyn JG; Cossburn MD; Reilly MM; Krishnan A; Doran M; Ryan AM; Coles AJ; Jones JL; Robertson NP
    J Neurol; 2010 Jun; 257(6):913-9. PubMed ID: 20049473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distal Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19 Vaccination in a Patient with Solitary Plasmacytoma: A Case Report and Literature Review.
    Kubota T; Shijo T; Ikeda K; Mitobe Y; Umezawa S; Misu T; Hasegawa T; Aoki M
    Intern Med; 2023; 62(16):2419-2425. PubMed ID: 37587059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
    Vina ER; Fang AJ; Wallace DJ; Weisman MH
    Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demyelinating polyneuropathy associated with chronic inactive hepatitis B infection.
    Babatin MA; AlJohani A
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33766960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy.
    Kuitwaard K; Hahn AF; Vermeulen M; Venance SL; van Doorn PA
    J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1331-6. PubMed ID: 25515502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study.
    Markvardsen LH; Sindrup SH; Christiansen I; Olsen NK; Jakobsen J; Andersen H;
    Eur J Neurol; 2017 Feb; 24(2):412-418. PubMed ID: 28000311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nerve Ultrasound and Electrophysiology for Therapy Monitoring in Chronic Inflammatory Demyelinating Polyneuropathy.
    Kerasnoudis A; Pitarokoili K; Gold R; Yoon MS
    J Neuroimaging; 2015; 25(6):931-9. PubMed ID: 26242571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and long-term characteristics of the subtypes of chronic inflammatory demyelinating polyneuropathy].
    Shimizu F; Nemoto J; Takeshita Y; Maeda T; Koga M; Kanda T
    Rinsho Shinkeigaku; 2022 Mar; 62(3):173-177. PubMed ID: 35228460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum neurofilament light chain does not detect self-reported treatment-related fluctuations in chronic inflammatory demyelinating polyneuropathy.
    Poser PL; Sajid GS; Beyer L; Hieke A; Schumacher A; Horstkemper L; Karl AS; Grüter T; Sgodzai M; Pitarokoili K; Gerwert K; Gold R; Fisse AL; Gisevius B; Motte J
    Eur J Neurol; 2024 Jan; 31(1):e16023. PubMed ID: 37539836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
    Hansen PN; Mohammed AA; Markvardsen LK; Andersen H; Tankisi H; Sindrup SH; Krøigård T
    J Peripher Nerv Syst; 2023 Sep; 28(3):425-435. PubMed ID: 37212187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of relapsed and refractory CIDP with ofatumumab: a first case report.
    Wang J; Xiang Q
    Front Immunol; 2024; 15():1437848. PubMed ID: 39144145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Modern aspects of diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy in children].
    Kozyreva AA; Bembeeva RT; Druzhinina ES; Zavadenko NN; Kolpakchi LM; Pilia SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):58-68. PubMed ID: 38465811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A diagnosis challenge-L4 nerve root compression as the initial presentation of chronic inflammatory demyelinating polyneuropathy.
    Cojocaru IM; Alexianu M; Bastian A; Sapira V; Herţea C; Cojocaru M
    Rom J Intern Med; 2012; 50(4):297-308. PubMed ID: 23610977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy.
    Wong AH; Fukami Y; Sudo M; Kokubun N; Hamada S; Yuki N
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):275-9. PubMed ID: 25814494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study.
    Mielke O; Bril V; Cornblath DR; Lawo JP; van Geloven N; Hartung HP; Lewis RA; Merkies ISJ; Sobue G; Durn B; Shebl A; van Schaik IN;
    J Peripher Nerv Syst; 2019 Mar; 24(1):72-79. PubMed ID: 30672067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.